Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

GDC-0879

SKU: orb1300873

Description

GDC-0879 is a potent and selective small molecule inhibitor of B-Raf (IC50 = 0.13 nM) with additional activity against c-Raf. It is a valuable research tool for investigating MAPK/ERK pathway signaling in cancer biology, utilized in both in vitro cellular assays and in vivo xenograft models to study oncogenic BRAF-driven proliferation.

Research Area

Signal Transduction

Images & Validation

Key Properties

CAS Number905281-76-7
MW334.37
Purity99.93% (May vary between batches)
FormulaC19H18N4O2
SMILESOCCn1cc(c(n1)-c1ccncc1)-c1ccc2\C(CCc2c1)=N\O
TargetRaf
SolubilityDMSO:150 mg/mL (448.6 mM);10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (5.98 mM)

Bioactivity

Target IC50
B-Raf:0.13 nM
In Vivo
In GDC-0879 treated mice, both cell line- and patient-derived BRAFV600E tumors exhibit stronger and more sustained pharmacodynamic inhibition (>90% for 8 hours) and improved survival compared to mutant KRAS-expressing tumors. Although there is involvement of activated RAF signaling in RAS-induced tumorigenesis, decreased time to progression is observed for some KRAS-mutant tumors following GDC-0879 administration. Whereas GDC-0879-mediated efficacy is associated strictly with B-RafV600E status, MEK inhibition also attenuates proliferation and tumor growth of cell lines expressing wild-type BRAF (81% KRAS mutant, 38% KRAS wild type). The responsiveness of B-RafV600E melanoma cells to GDC-0879 could be dramatically altered by pharmacologic and genetic modulation of PI3K pathway activity.
In Vitro
GDC-0879 also inhibits cellular pERK with IC50 of 63 nM. GDC-0879 shows comparable potency in A375 melanoma and Colo205 colorectal carcinoma cell lines, both of which are B-RafV600E mutant, with IC50 of 59 nM and 29 nM for pMEK1 inhibition respectively. GDC-0879 potently inhibits B-RafV600E in Malme3M cells with IC50 of 0.75 μM. GDC-0879 also shows EC50 values < 0.5 μM in many tumor cells (A375, 624, SK-MEL-28, Malme3M, C32, 928, 888, G-361, Colo205, Colo206, SW1417, CL34, and Colo201).

Storage & Handling

Storage-20°C
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

Raf, Raf kinases, inhibit, Inhibitor, GDC0879, GDC-0879, GDC 0879, AR 00341677, AR00341677, AR-00341677, B-Raf

Similar Products

  • GDC-0879 [orb1223694]

    >98% (HPLC)

    905281-76-7

    334.3718

    C19H18N4O2

    2 mg, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg, 200 mg, 500 mg, 1 g
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Key Properties

No computed properties available.

Protocol Information

Available Sizes

Select a size below

1 mg
$ 80.00
2 mg
$ 90.00
5 mg
$ 120.00
1 ml x 10 mM (in DMSO)
$ 120.00
10 mg
$ 160.00
25 mg
$ 270.00
50 mg
$ 420.00
100 mg
$ 640.00
200 mg
$ 890.00
DispatchUsually dispatched within 5-10 working days
Bulk Enquiry